HAE Haemonetics Corporation
HAE Haemonetics Corporation
Healthcare · Medical Devices
Market read
Scan convergence 1 scan as of 2026-10-23 1 bull converging
POC $59.89 · VWAP $75.84 · +56.3% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Coverage
1 watchlist
HAE Price Structure
Loading timeframes…
Peers
Every watchlist HAE belongs to, members best 30-day change first — HAE highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@monster-discoveries
Reported EPS $1.14 versus analyst consensus of $1.08 (+5.8%).
full note →Against street estimates
How HAE's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. A consensus out of line with the name's earlier estimates (opposite sign to all of them and over 3x their size) is not graded. EPS only.
News (last pull)
Headlines about HAE from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 15 days ago · Oct 8
- Haemonetics (HAE) Jumps As Citi Hikes Price Target To $123 - StocksToTrade
- Haemonetics stock surges 17% on CSL Plasma supply deal update
- Haemonetics Reports Q1 FY2027: Revenue $339.4M, Adjusted EPS $1.14, Raises FY27 Guidance — TradingView News
- Haemonetics Corporation Announces First Quarter Fiscal 2027 Financial Results Available on Investor Relations Website | Haemonetics Corporation
- Haemonetics Corporation Announces Fourth Quarter Fiscal 2026 Financial Results Available on Investor Relations Website | Nasdaq
“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.
HAE research tape
74 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.